BRET-based ligand binding on BMG readers

Dr Kevin Pfleger (Director Biomedical Innovation, University of Western Australia, Australia)

  • Company/University: The University of Western Australia, Harry Perkins Institute of Medical Research and Dimerix Limited
  • Interviewee: Kevin Pfleger
  • Products used: PHERAstar and CLARIOstar
  • Method: ligand binding of GPCRs, protein-protein interaction, luminescence, BRET, NanoBRET, competitive binding

Kevin Pfleger from the University of Western Australia, Harry Perkins Institute of Medical Research and Dimerix Limited talks about his experience with NanoBRET assays on the the CLARIOstar® and PHERAstar®FSX plate readers. For more details on BRET and luminescence detection on the CLARIOstar, you can have a look at our CLARIOstar Plus luminescence flyer.